Business Description
Kainos Medicine Inc
ISIN : KR7284620002
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 40.96 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.8 | |||||
Beneish M-Score | -1.75 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 1.7 | |||||
3-Year EPS without NRI Growth Rate | -0.4 | |||||
3-Year FCF Growth Rate | -18.4 | |||||
3-Year Book Growth Rate | -7.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.7 | |||||
9-Day RSI | 70.96 | |||||
14-Day RSI | 67.85 | |||||
6-1 Month Momentum % | -15.67 | |||||
12-1 Month Momentum % | -50.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.34 | |||||
Quick Ratio | 3.34 | |||||
Cash Ratio | 3.2 | |||||
Days Sales Outstanding | 114.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.4 | |||||
Shareholder Yield % | 6.67 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 76.77 | |||||
Operating Margin % | -6274.65 | |||||
Net Margin % | -5699.37 | |||||
FCF Margin % | -6853.31 | |||||
ROE % | -81.27 | |||||
ROA % | -49.3 | |||||
ROIC % | -125.26 | |||||
ROC (Joel Greenblatt) % | -357.43 | |||||
ROCE % | -69.08 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 477.88 | |||||
PB Ratio | 10.87 | |||||
Price-to-Tangible-Book | 11.69 | |||||
EV-to-EBIT | -7.05 | |||||
EV-to-EBITDA | -7.68 | |||||
EV-to-Revenue | 418.4 | |||||
EV-to-FCF | -4.45 | |||||
Price-to-Net-Current-Asset-Value | 16.22 | |||||
Price-to-Net-Cash | 17.8 | |||||
Earnings Yield (Greenblatt) % | -14.15 | |||||
FCF Yield % | -14.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kainos Medicine Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 267.311 | ||
EPS (TTM) (â‚©) | -546 | ||
Beta | 1.39 | ||
Volatility % | 39.01 | ||
14-Day RSI | 67.85 | ||
14-Day ATR (â‚©) | 452.392765 | ||
20-Day SMA (â‚©) | 3205.5 | ||
12-1 Month Momentum % | -50.63 | ||
52-Week Range (â‚©) | 2275 - 6040 | ||
Shares Outstanding (Mil) | 27.92 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kainos Medicine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kainos Medicine Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kainos Medicine Inc Frequently Asked Questions
What is Kainos Medicine Inc(XKRX:284620)'s stock price today?
When is next earnings date of Kainos Medicine Inc(XKRX:284620)?
Does Kainos Medicine Inc(XKRX:284620) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |